Disminución del transportador de dopamina estriatal en primeros episodios psicóticos de pacientes esquizofrénicos tratados con risperidona
Authors:
- J.J. MateosJMJ.J. Mateos
- F. LomeñaFLF. Lomeña
- E. ParelladaEPE. Parellada
- M. FontMFM. Font
- E. FernándezEFE. Fernández
- J. PaviaJPJ. Pavia
- A. PratsAPA. Prats
- M. BernardoMBM. Bernardo
- 1 June 2006
- journal article
- Published by Elsevier in Revista Española de Medicina Nuclear
- Vol. 25 (3) , 159-165
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-upThe British Journal of Psychiatry, 2002
- Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [123I]IBZM SPECT studyPsychiatry Research: Neuroimaging, 2001
- Imaging of the dopaminergic system in parkinsonism with SPETNuclear Medicine Communications, 2001
- The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonismEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- New atypical antipsychotic medicationsJournal of Psychiatric Research, 1998
- Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT1997
- Abnormal Movements in Never-Medicated Indian Patients with SchizophreniaThe British Journal of Psychiatry, 1996
- Parkinsonism in neuroleptic-naive schizophrenic patientsAmerican Journal of Psychiatry, 1993
- Neurologic Approach to Drug-Induced Movement DisordersSouthern Medical Journal, 1990
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987